Association between the anticancer efficacy of cabazitaxel and toll-like receptor 4 mediating signaling pathways in metastatic castration-resistant prostate cancer cells.
Gamze Guney EskilerAsuman Deveci OzkanIsil Ezgi EryilmazUnal EgeliGulsah CecenerPublished in: Human & experimental toxicology (2020)
Therefore, NF-κB activity may be a potential target for the efficacy of CAB in mCRPC cells.